March 16, 2017 / 8:28 PM / 5 months ago

BRIEF-Catabasis Pharma Q4 loss per share $0.47

March 16 (Reuters) - Catabasis Pharmaceuticals Inc

* Catabasis pharmaceuticals reports fourth quarter and full year 2016 financial results and recent corporate highlights

* Q4 loss per share $0.47

* Q4 earnings per share view $-0.52 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below